170 related articles for article (PubMed ID: 34762747)
1. Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis.
Wu YH; Chou CL; Chang HC
Clin Exp Dermatol; 2022 Apr; 47(4):692-699. PubMed ID: 34762747
[TBL] [Abstract][Full Text] [Related]
2. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
3. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
4. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
Mimouni I; Shulman J; Unes AA; Pavlovsky L; Pavlotsky F
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12936. PubMed ID: 38059681
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of 308-nm Monochromatic Excimer Lamp Versus Other Phototherapy Devices for Vitiligo: A Systematic Review with Meta-Analysis.
Lopes C; Trevisani VF; Melnik T
Am J Clin Dermatol; 2016 Feb; 17(1):23-32. PubMed ID: 26520641
[TBL] [Abstract][Full Text] [Related]
6. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
Ju HJ; Han JH; Kim MS; Lee SH; Shin JW; Choi M; Jeong KH; Han TY; Choi CW; Lee HJ; Oh SH; Lee SH; Kim DH; Shin J; Lee JH; Kim SS; Kang HY; Chang SE; Kim JS; Lee DY; Choi GS; Suh DH; Chan Kim Y; Park CJ; Kim KH; Lee AY; Chan Park K; Lee MH; Bae JM;
J Am Acad Dermatol; 2021 Jun; 84(6):1619-1627. PubMed ID: 33508387
[TBL] [Abstract][Full Text] [Related]
7. Both cardiovascular and cerebrovascular events are decreased following long-term narrowband ultraviolet B phototherapy in patients with vitiligo: a propensity score matching analysis.
Bae JM; Kim YS; Choo EH; Kim MY; Lee JY; Kim HO; Park YM
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):222-229. PubMed ID: 32702138
[TBL] [Abstract][Full Text] [Related]
8. Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.
Bae JM; Jung HM; Hong BY; Lee JH; Choi WJ; Lee JH; Kim GM
JAMA Dermatol; 2017 Jul; 153(7):666-674. PubMed ID: 28355423
[TBL] [Abstract][Full Text] [Related]
9. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
11. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
12. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of local prostaglandin analogues for vitiligo treatment: a systematic review and meta-analysis.
Chang HC; Guo SP
Expert Rev Clin Pharmacol; 2022 Mar; 15(3):341-349. PubMed ID: 35473496
[TBL] [Abstract][Full Text] [Related]
14. The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo: A systematic review and meta-analysis.
Hu M; Liao K; Lei W; Zhang R; Tu C
Int Immunopharmacol; 2021 Sep; 98():107910. PubMed ID: 34198237
[TBL] [Abstract][Full Text] [Related]
15. Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study.
Ko MJ; Tsai WC; Tsai PH; Hsu LY; Chien KL; Wu HY
J Am Acad Dermatol; 2023 Sep; 89(3):496-503. PubMed ID: 37236426
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
17. Are very high cumulative doses of narrowband UVB safe in vitiligo?
Momen S; Sarkany R
Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):220-221. PubMed ID: 28370729
[No Abstract] [Full Text] [Related]
18. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
[TBL] [Abstract][Full Text] [Related]
19. UVB phototherapy in the treatment of vitiligo: State of the art and clinical perspectives.
Bouceiro Mendes R; Alpalhão M; Filipe P
Photodermatol Photoimmunol Photomed; 2022 May; 38(3):215-223. PubMed ID: 34626483
[TBL] [Abstract][Full Text] [Related]
20. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
